Skip to main content

Rein Therapeutics, Inc.

RNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001420565

No open-market purchases or sales by Rein Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $42.3M in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in Rein Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
46
+2 vs. Q4 2025
Shares held
11.4M
+1.78M (+18.6%) vs. Q4 2025
Total value
$14.8M
+$3.67M (+32.9%) vs. Q4 2025
New holders
11
14 more added
Sold out
9
4 more reduced

4 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 46 institutions
Q1 2021: 52 institutionsQ2 2021: 47 institutionsQ3 2021: 43 institutionsQ4 2021: 43 institutionsQ1 2022: 42 institutionsQ2 2022: 37 institutionsQ3 2022: 33 institutionsQ4 2022: 19 institutionsQ1 2023: 19 institutionsQ2 2023: 17 institutionsQ3 2023: 16 institutionsQ4 2023: 20 institutionsQ1 2024: 23 institutionsQ2 2024: 29 institutionsQ3 2024: 32 institutionsQ4 2024: 31 institutionsQ1 2025: 39 institutionsQ2 2025: 36 institutionsQ3 2025: 40 institutionsQ4 2025: 48 institutionsQ1 2026: 46 institutionsQ2 2026: 59 institutions
Value heldQ1 2026: $14.8M
Q1 2021: $48.0MQ2 2021: $41.5MQ3 2021: $33.6MQ4 2021: $18.9MQ1 2022: $16.5MQ2 2022: $8.34MQ3 2022: $5.86MQ4 2022: $3.21MQ1 2023: $1.30MQ2 2023: $1.83MQ3 2023: $1.59MQ4 2023: $3.24MQ1 2024: $11.0MQ2 2024: $13.5MQ3 2024: $16.3MQ4 2024: $13.1MQ1 2025: $10.6MQ2 2025: $9.30MQ3 2025: $9.76MQ4 2025: $12.5MQ1 2026: $14.8MQ2 2026: $42.3M
Institutions holding RNTX and their total value by quarter
QuarterHoldersValue
Q2 202659$42.3M
Q1 202646$14.8M
Q4 202548$12.5M
Q3 202540$9.76M
Q2 202536$9.30M
Q1 202539$10.6M
Q4 202431$13.1M
Q3 202432$16.3M
Q2 202429$13.5M
Q1 202423$11.0M
Q4 202320$3.24M
Q3 202316$1.59M
Q2 202317$1.83M
Q1 202319$1.30M
Q4 202219$3.21M
Q3 202233$5.86M
Q2 202237$8.34M
Q1 202242$16.5M
Q4 202143$18.9M
Q3 202143$33.6M
Q2 202147$41.5M
Q1 202152$48.0M

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Rein Therapeutics, Inc.; share changes are against Q4 2025.

Institutions holding RNTX in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Voss Capital, LLC4,388,362$5.70M0.33%+144,393+3.4%Added
BIOS Capital Management, LP1,982,375$2.58M4.87%+291,624+17.2%Added
Vanguard Capital Management LLC998,521$1.30M0.00%+998,521New
University of Texas/Texas Am Investment Managment Co511,610$665.1K0.10%00.0%Unchanged
Cable Car Capital LLC420,000$546.0K0.19%00.0%Unchanged
Prosight Management, LP411,600$535.1K0.09%−31,000−7.0%Reduced
Sigma Planning Corp348,677$453.3K0.01%+101,400+41.0%Added
Geode Capital Management, LLC344,690$448.2K0.00%+60,135+21.1%Added
Texas Capital Bank Wealth Management Services Inc273,625$355.7K0.02%+11,500+4.4%Added
Gagnon Securities LLC239,520$311.4K0.07%−700−0.3%Reduced
Senvest Management, LLC230,895$300.2K0.01%00.0%Unchanged
Palogic Value Management, L.P.180,000$234.0K0.10%+180,000New
Vanguard Fiduciary Trust Co154,512$200.9K0.00%+154,512New
ABS Direct Equity Fund LLC125,000$162.5K0.12%00.0%Unchanged
Rock Creek Group, LP125,000$162.5K0.02%+25,000+25.0%Added
State Street Corp75,904$98.7K0.00%00.0%Unchanged
BlackRock, Inc.68,528$89.1K0.00%+13,522+24.6%Added
Northern Trust Corp64,136$83.4K0.00%+23,667+58.5%Added
Chicago Partners Investment Group LLC41,048$77.2K0.00%+10,000+32.2%Added
Northwestern Mutual Wealth Management Co42,440$55.2K0.00%00.0%Unchanged
Mercer Global Advisors Inc35,461$46.1K0.00%+17,500+97.4%Added
XTX Topco Ltd32,924$42.8K0.00%+32,924New
Two Sigma Securities, LLC31,713$41.2K0.00%+14,459+83.8%Added
Exencial Wealth Advisors, LLC30,528$39.7K0.00%+30,528New
Meridian Wealth Advisors, LLC28,486$37.0K0.00%00.0%Unchanged
Americana Partners, LLC27,302$35.5K0.00%+10,000+57.8%Added
Renaissance Technologies LLC24,500$31.9K0.00%+1,800+7.9%Added
Gleason Group, Inc.22,389$29.1K0.00%00.0%Unchanged
Ancora Advisors, LLC20,000$26.0K0.00%00.0%Unchanged
Sanders Morris Harris LLC20,000$26.0K0.00%+20,000New
Cane Capital Partners, LLC18,000$23.4K0.01%00.0%Unchanged
HRT Financial LP15,486$20.0K0.00%−17,751−53.4%Reduced
Annandale Capital, LLC15,026$20.0K0.00%00.0%Unchanged
Steel Peak Wealth Management LLC13,000$16.9K0.00%+13,000New
Vanguard Global Advisers, LLC12,774$16.6K0.00%+12,774New
HighTower Advisors, LLC10,000$13.0K0.00%00.0%Unchanged
Rockefeller Capital Management L.P.5,097$6.63K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)3,391$4.41K0.00%+1,434+73.3%Added
JFS Wealth Advisors, LLC1,590$2.07K0.00%00.0%Unchanged
US Bancorp1,250$1.63K0.00%00.0%Unchanged
UBS Group AG1,024$1.33K0.00%−8,492−89.2%Reduced
Newbridge Financial Services Group, Inc.97$1260.00%+97New
Ronald Blue Trust, Inc.20$260.00%00.0%Unchanged
Wells Fargo & Company20$260.00%+20New
Caitong International Asset Management Co., Ltd3$40.00%+3New
Acadian Asset Management LLC17$00.00%00.0%Unchanged
Citadel Advisors LLC0$00.00%−120,083−100.0%Sold out
Jane Street Group, LLC0$00.00%−61,960−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−58,995−100.0%Sold out
Two Sigma Investments, LP0$00.00%−41,709−100.0%Sold out
KG&L Capital Management,LLC0$00.00%−18,000−100.0%Sold out
Virtu Financial LLC0$00.00%−13,663−100.0%Sold out
Cetera Investment Advisers0$00.00%−12,364−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−70−100.0%Sold out
Bank of America Corp0$00.00%−42−100.0%Sold out
Vanguard Group Inc––––Not filed
Global Retirement Partners, LLC––––Not filed
New Millennium Group LLC––––Not filed
Motiv8 Investments LLC––––Not filed